Profil
Eva Gardyan-Eisenlohr currently works at Intendis GmbH, as Chief Legal Officer and Deutsche Biotech Innovativ AG, as Member-Supervisory Board.
Ms. Gardyan-Eisenlohr also formerly worked at Olympus Corp., as Global Chief Compliance Officer, Bayer Schering Pharma AG, as Head-Legal Department, and Bayer Pharma AG, as General Counsel & Group Data Protection Officer from 2016 to 2020.
Postes actifs de Eva Gardyan-Eisenlohr
| Sociétés | Poste | Début |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Directeur/Membre du Conseil | - |
Intendis GmbH
Intendis GmbH Pharmaceuticals: MajorHealth Technology Specializes in dermatological drugs | Conseiller Juridique Général | - |
Anciens postes connus de Eva Gardyan-Eisenlohr
| Sociétés | Poste | Fin |
|---|---|---|
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Conseiller Juridique Général | 01/01/2020 |
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Conseiller Juridique Général | - |
| OLYMPUS CORPORATION | Compliance Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
Intendis GmbH
Intendis GmbH Pharmaceuticals: MajorHealth Technology Specializes in dermatological drugs | Health Technology |
Olympus Corp.
Olympus Corp. Medical SpecialtiesHealth Technology Manufactures and sells precision machineries and instruments | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG Financial ConglomeratesFinance Invests in companies which are involved in innovative business concepts and technologies | Finance |
















